Acer Therapeutics Inc (ACER)

Etorro trading 970x250
Acer Therapeutics Inc (ACER) Logo

About Acer Therapeutics Inc

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was founded in 2013 and is headquartered in Newton, Massachusetts. Address: One Gateway Center, Newton, MA, United States, 02458

Acer Therapeutics Inc News and around…

Latest news about Acer Therapeutics Inc (ACER) common stock and company :

12 Health Care Stocks Moving In Monday's Pre-Market Session
22 Nov, 2021 FinancialContent

Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's ...

A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street
22 Nov, 2021 FinancialContent

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones tumbled over 260 points in the ...

5 Stocks To Watch For November 22, 2021
22 Nov, 2021 FinancialContent

Some of the stocks that may grab investor focus today are: Wall Street expects Agilent Technologies, Inc. (NYSE: A) to report ...

Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update
19 Nov, 2021 Yahoo! Finance

NEWTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the third quarter ended September 30, 2021 and provided an update on Acer’s recent corporate developments. “This quarter was all about preparing regulatory filings to advance our pipeline pr

Acer Listed on Dow Jones Sustainability Indices (DJSI) for Eighth Straight Year in 2021
18 Nov, 2021 FinancialContent
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
27 Oct, 2021 FinancialContent

Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market ...

Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation
26 Oct, 2021 Yahoo! Finance

Key ACER-001 formulation composition of matter patent strengthens proprietary position in U.S. until 2036NEWTON, Mass. and GENEVA, Switzerland, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Patent and Trademark Office (USPTO) has issued a new U.S. patent to Acer for certain claims related to ACER-001 (sodium phenylbutyrate). Patent 11

Acer Expands Lineup of Eco-friendly Vero Products
13 Oct, 2021 FinancialContent
Acer Therapeutics Inc. (NASDAQ:ACER): Are Analysts Optimistic?
09 Oct, 2021 Yahoo! Finance

Acer Therapeutics Inc. ( NASDAQ:ACER ) is possibly approaching a major achievement in its business, so we would like to...

Acer's (ACER) NDA for ACER-001 in UCD Gets FDA Acceptance
07 Oct, 2021 Yahoo! Finance

The FDA accepts Acer's (ACER) NDA for ACER-001 (sodium phenylbutyrate) for the treatment of patients with urea cycle disorders. A decision is due on Jun 5, 2022. Stock up.

FDA Approves NDA for Acer Therapeutics’ ACER-001; Shares Rise
07 Oct, 2021 Yahoo! Finance

Shares of Acer Therapeutics Inc. (ACER) closed 16.5% higher on Wednesday and then declined 5.51%, at the time of writing, in early trade on Thursday. The stock price moved after the pharmaceutical company and its collaboration partner, Relief Therapeutics Holding SA, received the U.S. Food and Drug Administration’s (FDA) green light to file the New Drug Application (NDA) for ACER-001. ACER-001 (sodium phenylbutyrate) is designed for the treatment of patients with various inborn errors of metabol

Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation
07 Oct, 2021 Yahoo! Finance

Notice of allowance of ACER-001 formulation composition of matter patent application strengthens proprietary position in U.S. until 2036NEWTON, Mass. and GENEVA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Acer’s patent application No. 17/196,416 for certain cl

40 Biggest Movers From Yesterday
07 Oct, 2021 FinancialContent

Gainers Volcon, Inc. (NASDAQ: VLCN) shares jumped 97.5% to settle at $10.86 on Wednesday as the company priced its IPO at $5.50 ...

Mid-Afternoon Market Update: US Stocks Turn Positive; Hovnanian Enterprises Shares Slide
06 Oct, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded up 0.08% to 34,342.65 while the NASDAQ rose 0.38% to 14,489.14. The S&P also ...

12 Health Care Stocks Moving In Wednesday's Intraday Session
06 Oct, 2021 FinancialContent

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares moved upwards by 44.73% to $3.58 during Wednesday's regular ...

Mid-Day Market Update: Dow Tumbles Over 300 Points; Acer Therapeutics Shares Jump
06 Oct, 2021 FinancialContent

Midway through trading Wednesday, the Dow traded down 0.92% to 33,997.95 while the NASDAQ fell 0.49% to 14,362.47. The S&P also ...

26 Stocks Moving In Wednesday's Mid-Day Session
06 Oct, 2021 FinancialContent

Gainers Voyager Therapeutics, Inc. (NASDAQ: VYGR) shares jumped 54.1% to $3.8050 after the company announced licensing option ...

Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders
06 Oct, 2021 Yahoo! Finance

FDA sets PDUFA target action date of June 5, 2022NEWTON, Mass. and GENEVA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for ACER-001 (sodium phenylbutyrate) for the treatment of patients with Urea Cycle Disorders (UCDs). The FDA has assigned a P

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Acer Therapeutics Stock Jumps As UCD Candidate Is Under FDA Review
06 Oct, 2021 FinancialContent

TheFDA has accepted for reviewAcer Therapeutics Inc(NASDAQ: ACER) and its partner,Relief Therapeutics Holding ...

15 Stocks Moving in Wednesday's Pre-Market Session
06 Oct, 2021 FinancialContent

Gainers Acer Therapeutics Inc. (NASDAQ: ACER) rose 23.2% to $3.07 in pre-market trading. Acer Therapeutics and Relief Therapeutics ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
16 Sep, 2021 FinancialContent

Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The ...

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Acer Therapeutics Inc. common stock – ACER
06 Sep, 2021 FinancialContent
12 Health Care Stocks Moving In Monday's After-Market Session
31 Aug, 2021 FinancialContent

Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock moved upwards by 20.91% to $0.68 during Monday's after-market session. Today's ...

Acer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
30 Aug, 2021 FinancialContent
22 Million in Cash for this NASDAQ insures Operating Capital into Mid 2022; FDA Review of ACER 001 Bodes well for Acer Therapeutics Inc. (NASDAQ: ACER)
24 Aug, 2021 FinancialContent
Opexa Therapeutics, Inc. (ACER) Reports Q2 Loss, Misses Revenue Estimates
10 Aug, 2021 Yahoo! Finance

Opexa Therapeutics, Inc. (ACER) delivered earnings and revenue surprises of 36.11% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Acer Therapeutics Reports Q2 2021 Financial Results and Provides Corporate Update
10 Aug, 2021 FinancialContent
Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
09 Aug, 2021 FinancialContent
20 Stocks Moving in Monday's Pre-Market Session
09 Aug, 2021 FinancialContent

Gainers Windtree Therapeutics, Inc. (NASDAQ: WINT) shares rose 55.8% to $2.82 in pre-market trading after dropping over 10% on ...

Acer Therapeutics Inc (ACER) is a NASDAQ Common Stock listed in , ,

970x250